We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 367

Curtain lifted on proposed amended PM(NOC) Regulations
  • Gowling WLG
  • Canada
  • July 17 2017

The curtain has been lifted to reveal the proposed amendments to the Patented Medicines (Notice of Compliance) Regulations (the “Amended


UK Supreme Court introduces doctrine of equivalents in patent law in Actavis v Lilly
  • Gowling WLG
  • European Union, United Kingdom
  • July 13 2017

In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a


$644 million patent infringement judgment is largest in Canadian history
  • Gowling WLG
  • Canada
  • July 11 2017

In its decision in The Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 637, the Federal Court of Canada has awarded the successful


Supreme Court of Canada Bulletin - June 30, 2017
  • Gowling WLG
  • Canada
  • June 30 2017

On appeal from a judgment of the Federal Court of Appeal (2015 FCA 158) affirming a decision of Rennie J. (2014 FC 638


Supreme Court of Canada rejects the Promise of the Patent Doctrine
  • Gowling WLG
  • Canada
  • June 30 2017

The Supreme Court of Canada released on June 30, 2017 its long-awaited decision (available here) addressing the issue of the "promise of the patent


UK Parliament continues legislative steps needed for ratification of UPC Agreement
  • Gowling WLG
  • European Union, United Kingdom
  • June 27 2017

With the UK Parliament sitting again, following the drama of the June 2017 General Election, the Government is now continuing with the national


Patent exhaustion in Canada and the UK
  • Gowling WLG
  • Canada, European Union, United Kingdom
  • June 12 2017

The doctrine of “patent exhaustion” provides that once a patentee sells one of its products, it can no longer exercise control over the specific


NAFTA renegotiation and modernization consultations
  • Gowling WLG
  • Canada, USA
  • June 5 2017

The Government of Canada is requesting submissions from persons interested in the renegotiation and modernization of the North American Free Trade


The basics of patent law: the Unified Patent Court and the Unitary Patent
  • Gowling WLG
  • European Union, United Kingdom
  • May 17 2017

Gowling WLG's intellectual property experts explain the Unified Patent Court and Unitary Patent, as part of their series of articles titled 'The


What the Supreme Court of Canada was not told about patent utility
  • Gowling WLG
  • Canada
  • May 11 2017

On November 8, 2016 the Supreme Court of Canada (“SCC”) heard an appeal by Astrazeneca regarding the validity of a patent covering its NEXIUM product